News
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...
Take advantage of this Bet365 bonus code NYPBET and get a $150 bonus for placing a $5 bet, win or lose. Thanks to Brunson’s ...
23h
Zacks Investment Research on MSNPharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New DealsBayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...
The duality is a hallmark of Greater Boston’s lab market these days. Bright spots surely remain, such as big new lab ...
1d
Zacks Investment Research on MSNGSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease DrugGSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston ...
The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...
MLB player prop bets and odds for Spencer Enochs Torkelson on Wednesday, May 14, 2025, as the Detroit Tigers take on the ...
GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journal reported May 14. The agreement includes a $1.2 billion ...
Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash ...
With its purchase of Boston Pharmaceuticals' drug, GSK extends a streak of dealmaking it's undertaken to build a liver ...
GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results